Keros Therapeutics, Inc. (KROS)

NASDAQ: KROS · Real-Time Price · USD

9.55

-0.64 (-6.28%)

At close: Apr 1, 2025, 4:00 PM

9.53

-0.02 (-0.19%)

After-hours: Apr 1, 2025, 5:16 PM EDT

Keros Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2018
Period Ending	Apr '25 Apr 1, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2018
Market Capitalization	387	641	1,191	1,323	1,369	1,635	Upgrade
Market Cap Growth	-46.17%	-46.17%	-9.94%	-3.39%	-16.27%	-	Upgrade
Enterprise Value	-154	130	918	1,084	1,149	1,502	Upgrade
Last Close Price	9.55	15.83	39.76	48.02	58.51	70.54	Upgrade
PS Ratio	100.71	180.63	7888.64	-	68.11	-	Upgrade
PB Ratio	0.68	1.12	3.59	4.77	5.63	6.25	Upgrade
P/TBV Ratio	1.12	1.12	3.59	4.77	5.63	6.25	Upgrade
EV/Sales Ratio	36.57	36.57	6076.87	-	57.16	-	Upgrade
Debt / Equity Ratio	0.03	0.03	0.04	0.05	0.00	0.00	Upgrade
Asset Turnover	0.01	0.01	0	-	0.08	-	Upgrade
Quick Ratio	20.56	20.56	13.63	16.92	20.96	37.04	Upgrade
Current Ratio	21.45	21.45	14.25	17.27	21.23	37.27	Upgrade
Return on Equity (ROE)	-41.46%	-41.46%	-50.19%	-40.22%	-23.27%	-34.60%	Upgrade
Return on Assets (ROA)	-26.73%	-26.73%	-31.39%	-25.53%	-13.43%	-20.80%	Upgrade
Return on Capital (ROIC)	-28.12%	-28.12%	-33.33%	-26.82%	-13.90%	-21.65%	Upgrade
Earnings Yield	-48.37%	-29.22%	-12.84%	-7.91%	-4.29%	-2.77%	Upgrade
FCF Yield	-42.03%	-25.39%	-10.66%	-5.39%	-4.61%	-2.27%	Upgrade
Buyback Yield / Dilution	-27.14%	-27.13%	-16.66%	-8.17%	-50.48%	-566.41%	Upgrade

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q